DIfferences in prostate treatment between ROI and Northern Ireland, and measuring patient opinions

Bookmark and Share
Published: 13 Nov 2013
Views: 3927
Dr Anna Gavin - North Ireland Cancer Registry, Queens University, Belfast, UK

Dr Gavin talks to ecancertv at the UK's National Cancer Research Institute ( NCRI ) 2013 meeting about a study looking at the effects of prostate cancer treatment comparing the Republic of Ireland with Northern Ireland, UK.

There are differences in services such as testing, leading to 30% more diagnosis in the ROI than Northern Ireland; in some cases overdiagnosis.

The team carried out a postal survey of men diagnosed with prostate cancer, receiving 3300 replies with very useful quality of life information leaving us in a better position to inform men about the treatment options associated with prostate cancer.